Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
284
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
-277K
-
Total reported value, excl. options
-
$1.13B
-
Value change
-
-$26.3M
-
Put/Call ratio
-
1.12
-
Number of buys
-
139
-
Number of sells
-
-98
-
Price
-
$100.59
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q4 2021
329 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 284 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
of 30.2M outstanding shares and own 37.09% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.42M shares), VANGUARD GROUP INC (1.31M shares), STATE STREET CORP (625K shares), GEODE CAPITAL MANAGEMENT, LLC (374K shares), Skandinaviska Enskilda Banken AB (publ) (279K shares), Invesco Ltd. (272K shares), NORTHERN TRUST CORP (261K shares), Bank of New York Mellon Corp (252K shares), CITADEL ADVISORS LLC (229K shares), and BAKER BROS. ADVISORS LP (201K shares).
This table shows the top 284 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.